X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

FULC

Closed

Fulcrum Therapeutics Inc

6.84
-0.04 (-0.58%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 6.88
Day's Range: 6.155 - 6.91
Send
When Written:
 
2.805
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company that focuses on developing small molecule therapies to treat genetically defined diseases. The company's proprietary product platform leverages insights into gene regulation and epigenetics to identify and develop potential therapies for rare genetic diseases. Fulcrum's lead product candidate, losmapimod, is being developed for the treatment of facioscapulohumeral muscular dystrophy (FSHD), a rare genetic disease that causes progressive muscle weakness and wasting. The company is also developing other product candidates for the treatment of other rare genetic diseases. Fulcrum Therapeutics Inc was founded in 2016 and is headquartered in Cambridge, Massachusetts.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X